The age-adjusted suicide rate increased in 2021 and 2022, following a decline from 2018 to 2020, reaching 14.2 per 100,000 standard population in 2022.

Regional anesthesia may reduce chronic postsurgical pain up to 6 months and mitigate risk for persistent opioid use after elective noncardiac surgery.

Emotion regulation and pain catastrophizing influenced pain severity and interference in patients taking opioid medications for chronic noncancer pain.

The FDA announced that it has accepted the supplemental sNDA for roflumilast foam 0.3% in those with scalp and body psoriasis over 12.

Patients with RA face greater health care expenditures and a lower quality of life compared with the general population.

Gamified digital mental health interventions (DMHIs) may offer benefits for youth with attention-deficit/hyperactivity disorder (ADHD) or depressive disorder.

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.